A Biden administration will likely bring in a fresh set of policy approaches to drug prices after four years of executive orders and limited federal action. Curious about what might influence the new administration?

Here’s a “reading list” of drug-pricing commentary from some of Biden’s current policy advisors. We’ll keep updating as more people — and more papers — emerge.

  • Andy Slavitt was the former Centers for Medicare and Medicaid Services (CMS) director under the Obama administration and is currently a senior advisor to the Bipartisan Policy Center.
  • Eliot Fishman is the Senior Director of Health Policy at Families USA. He previously served as the Director of State Demonstrations Group at the  Centers for Medicaid and CHIP Services under the Obama administration.